Alnylam Pharmaceuticals overview

Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
The staff at Alnylam Pharmaceuticals come from unusually diverse demographic backgrounds. The company is 48.6% female and 41.1% ethnic minorities. Even though it has great demographic diversity, Alnylam Pharmaceuticals notably lacks in political diversity. It has an unusually high proportion of employees who are members of the Democratic Party, at 90.0%. Despite having coworkers who agree with each other about politics, employees at Alnylam Pharmaceuticals tend to have relatively short tenures. Staff members usually stay with the company for 2.2 years. The average employee at Alnylam Pharmaceuticals makes $67,509 per year. Pay at Alnylam Pharmaceuticals is significantly lower than some of its highest paying competitors, like bluebird bio, Cubist Pharmaceuticals, and Millennium Pharmaceuticals, which pay $86,630, $84,228, and $82,461, respectively.
Based in Cambridge, Massachusetts, Alnylam Pharmaceuticals is a medium-sized pharmaceutical company with 500 employees and a revenue of $66.0M.

The Organization’s Mission

Build a top-tier, independent biopharmaceutical company founded on RNAi.

Industry

Pharmaceutical

Revenue

$66.0M

Employees

500

Founded in

2002

Headquarters

Cambridge, MA

Website

alnylam.com

Organization Type

Public

Is This Your Company?

The team at Alnylam Pharmaceuticals

Key People
  • John Maraganore (ceo)
  • Phillip Sharp (founder)

The Culture At Alnylam Pharmaceuticals

Information provided by the company
We seek a marketer who is passionate about science and deeply motivated by delivering value to patients and their families.
Alnylam is the industry leader in the translation of RNA interference (RNAi) into a new class of innovative medicines with the potential to address the unmet needs of patients with debilitating diseases.

What do people say about Alnylam Pharmaceuticals

Work at Alnylam Pharmaceuticals ? Share your experience anonymously.

What do you like about working for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals Rankings

Alnylam Pharmaceuticals is ranked #80 on the Best Pharmaceutical Companies to Work For in America list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Alnylam Pharmaceuticals Salaries

How much does Alnylam Pharmaceuticals pay?
The national average salary for an Alnylam Pharmaceuticals employee in the United States is $67,509 per year. Employees in the top 10 percent can make over $118,000 per year, while employees at the bottom 10 percent earn less than $38,000 per year.
9.6
Salary Score
Average Employee Earnings

Alnylam Pharmaceuticals Salaries By Job Title

While the average employee salary at Alnylam Pharmaceuticals is $67,509, there is a big variation in pay depending on the role. Some of the job titles with high salaries at Alnylam Pharmaceuticals are Manager, Program Management, Quality Assurance Manager, Senior Programmer, and Team Lead And Developer. A typical Manager, Program Management salary at Alnylam Pharmaceuticals is $119,639. To get a better sense of the salaries at Alnylam Pharmaceuticals, other roles such as Animal Care Technician and Data Entry Specialist can be considered as well. For comparison, the title Animal Care Technician at Alnylam Pharmaceuticals earns $27,361 per year.

Alnylam Pharmaceuticals careers

On average, employees at Alnylam Pharmaceuticals stay with the company for 2.2 years. Employees most commonly join Alnylam Pharmaceuticals after leaving Biogen. When they leave Alnylam Pharmaceuticals, they most frequently get their next job at Intuitive Surgical.

Average Length of Employment
Qiagen3.3 years

Alnylam Pharmaceuticals

2.2 years
Top Employers Before Alnylam Pharmaceuticals
Biogen17.9 %
Show More
Top Employers After Alnylam Pharmaceuticals
Show More
00

Do you Work At Alnylam Pharmaceuticals?

Help us make this company more transparent.

0

Alnylam Pharmaceuticals Financial Performance

9.0
Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Revenue

$10M - $100M

Founded in

2002

Organization type

Public

How Would You Rate The Company Culture Of Alnylam Pharmaceuticals?

Have you worked at Alnylam Pharmaceuticals? Help other job seekers by rating Alnylam Pharmaceuticals.

Alnylam Pharmaceuticals Competitors

Competitors of Alnylam Pharmaceuticals include bluebird bio, Cubist Pharmaceuticals, and Millennium Pharmaceuticals. Employees at bluebird bio earn more than most of the competition, with an average yearly salary of $86,630. The salaries at Cubist Pharmaceuticals average $84,228 per year, and the salaries at Millennium Pharmaceuticals come in at $82,461 per year.

Frequently Asked Questions about Alnylam Pharmaceuticals

When was Alnylam Pharmaceuticals founded?

Alnylam Pharmaceuticals was founded in 2002.

How many Employees does Alnylam Pharmaceuticals have?

Alnylam Pharmaceuticals has 500 employees.

How much money does Alnylam Pharmaceuticals make?

Alnylam Pharmaceuticals generates $66.0M in revenue.

What industry is Alnylam Pharmaceuticals in?

Alnylam Pharmaceuticals is in the pharmaceutical industry.

What is Alnylam Pharmaceuticals's mission?

Alnylam Pharmaceuticals's mission statement is "Build a top-tier, independent biopharmaceutical company founded on RNAi."

What type of company is Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals is a public company.

Who are Alnylam Pharmaceuticals's competitors?

Alnylam Pharmaceuticals competitors include Qiagen, Ironwood Pharmaceuticals, Ricerca Biosciences, Momenta Pharmaceuticals, AMRI, ARIAD Pharmaceuticals, Aptuit, BioReliance, Amneal Pharmaceuticals, Corium International, Emergent BioSolutions, Cubist Pharmaceuticals, PTC Therapeutics, ImmunoGen, bluebird bio, OncoMed Pharmaceuticals, GTx, Millennium Pharmaceuticals, Array BioPharma, Bachem.

Who works at Alnylam Pharmaceuticals?

John Maraganore (ceo)

Phillip Sharp (founder)

Are you an executive, HR leader, or brand manager at Alnylam Pharmaceuticals?

Claiming and updating your company profile on Zippia is free and easy.

You can find out what it is like to work at Alnylam Pharmaceuticals, also known as ALNYLAM PHARM INC, Alnylam Pharmaceuticals, Alnylam Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc. and Alnylam Pharmaceuticals, Inc..

Zippia gives an in-depth look into the details of Alnylam Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Alnylam Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Alnylam Pharmaceuticals. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of Alnylam Pharmaceuticals and its employees or that of Zippia.